Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Ernesto Sparrelid to Risk Factors

This is a "connection" page, showing publications Ernesto Sparrelid has written about Risk Factors.

 
Connection Strength
 
 
 
0.665
 
  1. Reese T, Gilg S, Böcker J, Wagner KC, Vali M, Engstrand J, Kern A, Sturesson C, Oldhafer KJ, Sparrelid E. Impact of the future liver remnant volume before major hepatectomy. Eur J Surg Oncol. 2024 11; 50(11):108660.
    View in: PubMed
    Score: 0.077
  2. Sparrelid E, Olthof PB, Dasari BVM, Erdmann JI, Santol J, Starlinger P, Gilg S. Current evidence on posthepatectomy liver failure: comprehensive review. BJS Open. 2022 11 02; 6(6).
    View in: PubMed
    Score: 0.068
  3. Huang Y, Santoni G, Petrick JL, Wocalewski V, Sparrelid E, Xie SH. Menopausal hormone therapy and risk of liver cancer in a Swedish population-based cohort study. J Natl Cancer Inst. 2026 Aug 01; 118(8):1478-1484.
    View in: PubMed
    Score: 0.022
  4. Romandini E, Perri G, Maekawa A, Bannone E, Sahakyan MA, Kleive DB, Ghorbani P, Marchegiani G, Montorsi R, Cattelani A, Gilg S, Fretland ÅA, Holmberg M, Sparrelid E, Labori KJ, Edwin B, Salvia R. Postpancreatectomy acute pancreatitis after distal pancreatectomy: tri-institutional international cohort. BJS Open. 2026 07 03; 10(4).
    View in: PubMed
    Score: 0.022
  5. Stoop TF, Croce C, Ishida H, Ali M, Javed AA, Halimi A, Oba A, Groot Koerkamp B, Leonhardt CS, Thiels CA, Rangelova E, Sparrelid E, Sotirova I, Leiting JL, Tauchi J, Kobayashi K, Klos M, Beuk LPM, Genova L, Mastronardi M, Kendrick ML, Mughal NA, Busch OR, Franklin O, Larsson P, Klaiber U, Schulick RD, Theijse RT, Strobel O, Ghorbani P, de Wilde RF, Rodriguez Franco S, Sugawara T, Wilmink JW, Messersmith W, Besselink MG, Wolfgang CL, Inoue Y, Truty MJ, Del Chiaro M. Neurogenic diarrhoea after superior mesenteric artery divestment or resection for pancreatic adenocarcinoma following preoperative chemotherapy: international multicentre retrospective study. BJS Open. 2026 05 12; 10(3).
    View in: PubMed
    Score: 0.022
  6. Stoop TF, van 't Land FR, Seelen LWF, Ali M, Sultan A, Javed AA, van Eijck CHJ, Thiels CA, Hewitt DB, Sparrelid E, Uzunoglu FG, Gehrisch OHF, Daams F, Ishida H, van Santvoort HC, Molenaar IQ, Leiting JL, Erdmann JI, Cappelle M, Ginesini M, Kendrick ML, Napoli N, Busch OR, Franklin O, Ghorbani P, Schulick RD, Dankha R, de Wilde RF, Welsch T, Te Riele W, Wolfgang CL, Besselink MG, Groot Koerkamp B, Boggi U, Truty MJ, Del Chiaro M, Hackert T. Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including arterial divestment or arterial resection. BJS Open. 2026 05 12; 10(3).
    View in: PubMed
    Score: 0.022
  7. Huang Y, Santoni G, Sparrelid E, Xie SH. Metformin use and the risk of liver cancer in a Swedish population-based cohort study. JNCI Cancer Spectr. 2026 May 09; 10(3).
    View in: PubMed
    Score: 0.022
  8. Maier E, Stättner S, Carrion-Alvarez L, Di Martino M, Olthof P, Primavesi F, Sochorova D, van Laarhoven S, Balakrishnan A, Breitkopf R, Buis CI, Cipriani F, Erdmann J, Frampton A, Fuks D, Gilg S, Gulla A, Lancellotti F, Margreiter C, Melloul E, Oberkofler C, Petritsch S, Raab H, Rahbari NN, Rappold D, Reiberger T, Ruzzenente A, Sallinen V, Schäfer B, Schnitzbauer AA, Serrablo A, Soreide K, Sparrelid E, Starlinger P, Stavrou GA, Tinguely P, Aldrighetti L, Dasari BVM, Donadon M, Dopazo C, Gruenberger T, Jonas E, Malik H, Viganó L, Siriwardena AK, Maglione M. The E-AHPBA - ESSO - Innsbruck consensus recommendations on peri- and postoperative management following liver resection. HPB (Oxford). 2026 Aug; 28(8):1005-1033.
    View in: PubMed
    Score: 0.021
  9. Suljagic A, Swartling O, Henningson ES, Ansorge C, Gilg S, Sparrelid E, Ghorbani P. Postoperative Cholangitis After Pancreatoduodenectomy: A Frequent Late Complication Demanding Standardized Prevention and Treatment Protocols. Ann Surg Oncol. 2025 Dec; 32(13):10007-10016.
    View in: PubMed
    Score: 0.021
  10. Sterner J, Andersson M, Olofsson A, Jansson H, Strömberg C, D'Souza M, Sturesson C, Sparrelid E, Gerling M, Gilg S, Engstrand J. Impact of post-hepatectomy liver failure on recurrence following major hepatectomy for colorectal cancer liver metastases. HPB (Oxford). 2025 Oct; 27(10):1309-1317.
    View in: PubMed
    Score: 0.020
  11. Swartling O, Reese T, Hasselgren K, Engstrand J, Kern AE, Baumgartner R, Ghorbani P, Sandström P, Sparrelid E, Oldhafer KJ, Björnsson B, Gilg S. Acute kidney injury after major hepatectomy: association with postoperative complications and post-hepatectomy liver failure. BJS Open. 2025 03 05; 10(2).
    View in: PubMed
    Score: 0.020
  12. Bonsdorff A, Kjeseth T, Kirkegård J, de Ponthaud C, Ghorbani P, Wennerblom J, Williamson C, Acher AW, Thillai M, Tarvainen T, Helanterä I, Uutela A, Sirén J, Kokkola A, Sahakyan M, Kleive D, Hagen R, Lund A, Nielsen MF, Vaillant JC, Fristedt R, Biörserud C, Bratlie SO, Tingstedt B, Labori KJ, Gaujoux S, Wigmore SJ, Hallet J, Sparrelid E, Sallinen V. International multicentre validation of the left pancreatectomy pancreatic fistula prediction models and development and validation of the combined DISPAIR-FRS prediction model. Br J Surg. 2025 03 04; 112(3).
    View in: PubMed
    Score: 0.020
  13. Reese T, Gilg S, Erdmann J, Jonas E, Oldhafer KJ, Sparrelid E. Future liver remnant volumetry: an E-AHPBA international survey of current practice among liver surgeons. HPB (Oxford). 2025 Jun; 27(6):861-868.
    View in: PubMed
    Score: 0.020
  14. Radkiewicz C, Ludvigsson JF, Sparrelid E, Emilsson L. Pancreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study. Eur J Cancer. 2025 Jan; 214:115140.
    View in: PubMed
    Score: 0.020
  15. Larsson P, Swartling O, Perri G, Vaez K, Holmberg M, Klevebro F, Gilg S, Sparrelid E, Ghorbani P. The impact of chronic obstructive pulmonary disease on risk for complications after pancreatoduodenectomy - a single centre cohort study. HPB (Oxford). 2025 Jan; 27(1):87-93.
    View in: PubMed
    Score: 0.019
  16. Villard C, Widman L, Sparrelid E, Bergquist A, Hagström H. The risk of cholangiocarcinoma in patients with MASLD is not increased compared to the general population. Scand J Gastroenterol. 2024 11; 59(11):1249-1251.
    View in: PubMed
    Score: 0.019
  17. Perri G, Romandini E, Marchegiani G, Ghorbani P, Sahakyan M, Holmberg M, Cattelani A, Fretland Å, Montorsi R, Rodrigues ID, Kleive D, Bannone E, Edwin B, Gilg S, Labori KJ, Sparrelid E, Salvia R. Postoperative Hyperamylasemia (POH) Is an Early Predictor of Pancreatic Fistula Occurrence and Severity After Distal Pancreatectomy: Results from a European Multicentric Study. Ann Surg. 2025 Aug 01; 282(2):291-298.
    View in: PubMed
    Score: 0.019
  18. Swartling O, Evans M, Larsson P, Perri G, Yarbakht D, Al-Kamil H, Gilg S, Holmberg M, Sparrelid E, Ghorbani P. Preoperative chronic kidney disease and complications after pancreatoduodenectomy: a retrospective cohort study. ANZ J Surg. 2023 10; 93(10):2492-2498.
    View in: PubMed
    Score: 0.018
  19. Stoop TF, von Gohren A, Engstrand J, Sparrelid E, Gilg S, Del Chiaro M, Ghorbani P. Risk Factors, Management, and Outcome of Gastric Venous Congestion After Total Pancreatectomy: An Underestimated Complication Requiring Standardized Identification, Grading, and Management. Ann Surg Oncol. 2023 Nov; 30(12):7700-7711.
    View in: PubMed
    Score: 0.018
  20. Ratti F, Marino R, Muiesan P, Zieniewicz K, Van Gulik T, Guglielmi A, Marques HP, Andres V, Schnitzbauer A, Irinel P, Schmelzle M, Sparrelid E, Fusai GK, Adam R, Cillo U, Lang H, Oldhafer K, Ruslan A, Ciria R, Ferrero A, Mazzaferro V, Cescon M, Giuliante F, Nadalin S, Golse N, Sulpice L, Serrablo A, Ramos E, Marchese U, Rosok B, Lopez-Lopez V, Clavien P, Aldrighetti L. Results from the european survey on preoperative management and optimization protocols for PeriHilar cholangiocarcinoma. HPB (Oxford). 2023 Nov; 25(11):1302-1322.
    View in: PubMed
    Score: 0.018
  21. Swartling O, Evans M, Larsson P, Gilg S, Holmberg M, Klevebro F, Löhr M, Sparrelid E, Ghorbani P. Risk factors for acute kidney injury after pancreatoduodenectomy, and association with postoperative complications and death. Pancreatology. 2023 Mar; 23(2):227-233.
    View in: PubMed
    Score: 0.017
  22. Stoop TF, Fröberg K, Sparrelid E, Del Chiaro M, Ghorbani P. Surgical management of severe pancreatic fistula after pancreatoduodenectomy: a comparison of early versus late rescue pancreatectomy. Langenbecks Arch Surg. 2022 Dec; 407(8):3467-3478.
    View in: PubMed
    Score: 0.017
  23. Bonsdorff A, Ghorbani P, Helanterä I, Tarvainen T, Kontio T, Belfrage H, Sirén J, Kokkola A, Sparrelid E, Sallinen V. Development and external validation of DISPAIR fistula risk score for clinically relevant postoperative pancreatic fistula risk after distal pancreatectomy. Br J Surg. 2022 10 14; 109(11):1131-1139.
    View in: PubMed
    Score: 0.017
  24. Larsson P, Feldt K, Holmberg M, Swartling O, Sparrelid E, Klevebro F, Ghorbani P. Preoperative heart disease and risk for postoperative complications after pancreatoduodenectomy. HPB (Oxford). 2022 11; 24(11):1854-1860.
    View in: PubMed
    Score: 0.017
  25. Perri G, Bortolato C, Marchegiani G, Holmberg M, Romandini E, Sturesson C, Bassi C, Sparrelid E, Ghorbani P, Salvia R. Pure biliary leak vs. pancreatic fistula associated: non-identical twins following pancreatoduodenectomy. HPB (Oxford). 2022 09; 24(9):1474-1481.
    View in: PubMed
    Score: 0.016
  26. Cornillet M, Jansson H, Schaffer M, Hertwig L, Berglin L, Zimmer CL, Johansson H, Ellis E, Isaksson B, Gonzalez-Galarza FF, Middleton D, Malmberg KJ, Sparrelid E, Björkström NK. Imbalance of Genes Encoding Natural Killer Immunoglobulin-Like Receptors and Human Leukocyte Antigen in Patients With Biliary Cancer. Gastroenterology. 2019 10; 157(4):1067-1080.e9.
    View in: PubMed
    Score: 0.013
  27. Sparrelid E, Hägglund H, Remberger M, Ringdén O, Lönnqvist B, Ljungman P, Andersson J. Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection. Bone Marrow Transplant. 1998 Oct; 22(8):795-800.
    View in: PubMed
    Score: 0.013
  28. Gilg S, Sparrelid E, Isaksson B, Lundell L, Nowak G, Strömberg C. Mortality-related risk factors and long-term survival after 4460 liver resections in Sweden-a population-based study. Langenbecks Arch Surg. 2017 Feb; 402(1):105-113.
    View in: PubMed
    Score: 0.011
  29. Sparrelid E, Hägglund H, Remberger M, Ljungman P, Malmborg AS, Winiarski J, Andersson J, Ringdén O. Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation. Transplant Proc. 1995 Dec; 27(6):3530.
    View in: PubMed
    Score: 0.011
  30. Spelt L, Sparrelid E, Isaksson B, Andersson RG, Sturesson C. Tumour growth after portal vein embolization with pre-procedural chemotherapy for colorectal liver metastases. HPB (Oxford). 2015 Jun; 17(6):529-35.
    View in: PubMed
    Score: 0.010
  31. Blennow O, Ljungman P, Sparrelid E, Mattsson J, Remberger M. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations. Transpl Infect Dis. 2014 Feb; 16(1):106-14.
    View in: PubMed
    Score: 0.009
  32. Omar H, Hägglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringdén O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction. Transpl Infect Dis. 2009 Oct; 11(5):393-9.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)